THOMPSON DAVIS & CO., INC. - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 83 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 6.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$15,000
+150.0%
875
+133.3%
0.03%
+135.7%
Q2 2018$6,0000.0%3750.0%0.01%
-12.5%
Q1 2018$6,0003750.02%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 475,200$6,877,0003.03%
Avoro Capital Advisors LLC 475,000$6,873,0002.64%
VHCP Management, LLC 451,400$6,532,0001.50%
Sio Capital Management, LLC 140,000$2,026,0001.15%
Opus Point Partners Management, LLC 75,000$1,085,0000.91%
Eventide Asset Management 620,200$8,974,0000.68%
Telemetry Investments, L.L.C. 55,000$796,0000.44%
Healthcare Value Capital, LLC 25,000$362,0000.40%
TFS CAPITAL LLC 259,916$3,761,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 672,562$9,732,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders